Add to ORKGTo determine the dose-limiting toxicities (DLTs) and the maximum tolerated doses (MTDs) of weekly high dose 5-fluorouracil (5FU) continuous infusion and leukovorin (LV) alternatively combined with oxaliplatin and irinotecan in patients with advanced tumors of the gastrointestinal (GI) tract.info:eu-repo/semantics/publishe
[[abstract]]Systemic chemotherapy for advanced gastric cancer is frequently associated with signific...
The purpose of this study was to evaluate the maximum tolerated dose (MTD) and recommended dose of o...
In patients with non-colon digestive carcinomas, various schedules and doses of 5-fluorouracil (5-FU...
Objective: To determine the dose-limiting toxicity (DLT) and the maximum-tolerated dose (MTD) of com...
[[abstract]]Objectives: To determine the maximum-tolerated dose (MTD) and dose-limiting toxicity (DL...
Introduction: Proper administration timing, dose-intensity, efficacy/toxicity ratio of triplet docet...
Background: Infusional fluorouracil (5-FU) and leucovorin (LV) with oxaliplatin is one of the curren...
Background: Oxaliplatin shows preclinical activity in many cancer cell lines that are resistant to c...
PURPOSE: We performed a phase I study of 5-fluorouracil (5-FU), cisplatin and irinotecan. METHODS: T...
Background: Standard chemotherapy for patients with metastatic colorectal cancer (mCRC) or gastric c...
BACKGROUND: Chemotherapy with oxaliplatin, fluorouracil (5-FU) and leucovorin (LV) has proven effica...
PURPOSE: To determine the feasibility, recommended doses, plasma pharmacokinetics, and antitumor act...
Objective: Oxaliplatin/ 5- Fluorouracil/ Leucovorin is an effective therapy for patients with metast...
Purpose: This trial was conducted to determine whether high-dose fluorouracil (FU) given as a weekly...
This is a phase I study to determine the maximum tolerated dose (MTD) and toxicity of a combination ...
[[abstract]]Systemic chemotherapy for advanced gastric cancer is frequently associated with signific...
The purpose of this study was to evaluate the maximum tolerated dose (MTD) and recommended dose of o...
In patients with non-colon digestive carcinomas, various schedules and doses of 5-fluorouracil (5-FU...
Objective: To determine the dose-limiting toxicity (DLT) and the maximum-tolerated dose (MTD) of com...
[[abstract]]Objectives: To determine the maximum-tolerated dose (MTD) and dose-limiting toxicity (DL...
Introduction: Proper administration timing, dose-intensity, efficacy/toxicity ratio of triplet docet...
Background: Infusional fluorouracil (5-FU) and leucovorin (LV) with oxaliplatin is one of the curren...
Background: Oxaliplatin shows preclinical activity in many cancer cell lines that are resistant to c...
PURPOSE: We performed a phase I study of 5-fluorouracil (5-FU), cisplatin and irinotecan. METHODS: T...
Background: Standard chemotherapy for patients with metastatic colorectal cancer (mCRC) or gastric c...
BACKGROUND: Chemotherapy with oxaliplatin, fluorouracil (5-FU) and leucovorin (LV) has proven effica...
PURPOSE: To determine the feasibility, recommended doses, plasma pharmacokinetics, and antitumor act...
Objective: Oxaliplatin/ 5- Fluorouracil/ Leucovorin is an effective therapy for patients with metast...
Purpose: This trial was conducted to determine whether high-dose fluorouracil (FU) given as a weekly...
This is a phase I study to determine the maximum tolerated dose (MTD) and toxicity of a combination ...
[[abstract]]Systemic chemotherapy for advanced gastric cancer is frequently associated with signific...
The purpose of this study was to evaluate the maximum tolerated dose (MTD) and recommended dose of o...
In patients with non-colon digestive carcinomas, various schedules and doses of 5-fluorouracil (5-FU...